Evidence map›Paper›PMID 26668527›Full record

ArticleUlusal cerrahi dergisi2015

The effect of laparoscopic sleeve gastrectomy on morbid obesity and obesity-related comorbidities: A cohort study.

Süleyman Çetinkünar, Hasan Erdem, Recep Aktimur, Mehmet Aziret, Sabri Özdaş, Banu Yürekli, Fahri Yetişir

Open access · greenAbstract read
In one paragraph

Article in Ulusal cerrahi dergisi, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Sleeve gastrectomy in situsinversustotalis case.Northern clinics of Istanbul · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Süleyman ÇetinkünarClinic of General Surgery, Adana Numune Training and Research Hospital, Adana, Turkey.
Hasan ErdemClinic of General Surgery, Adana Numune Training and Research Hospital, Adana, Turkey.
Recep AktimurClinic of General Surgery, Samsun Training and Research Hospital, Samsun, Turkey.
Mehmet AziretClinic of General Surgery, Kars State Hospital, Kars, Turkey.
Sabri ÖzdaşClinic of General Surgery, Adıyaman Training and Research Hospital, Adıyaman, Turkey.
Banu YürekliDepartment of Endocrinology, Ege University Faculty of Medicine, İzmir, Turkey.
Fahri YetişirClinic of General Surgery, Atatürk Training and Research Hospital, Ankara, Turkey.
Adıyaman University · TREge University · TRSamsun University · TRSivas State Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBariatric surgery with multidisciplinary management is a more effective method to treat morbid obesity and obesity-related comorbidities compared with nonsurgical treatments. Laparoscopic sleeve gastrectomy (LSG) was initially performed as the first stage of biliopancreatic diversion with duodenal switch in the super-obese population. In the past few years, however, LSG has been performed as a definitive procedure because of its promising early and midterm results. The aim of this study is to evaluate the efficacy of our initial LSG series of 73 patients on excess weight loss (EWL) and resolution of obesity-related comorbidities in short-term follow-up. MATERIAL AND

methodsFrom March 2013 to May 2014, 78 morbid obese patients with an average body mass index (BMI) of 46.3 kg/m(2) underwent LSG. There is a 9-month follow-up period on average. Five patients were excluded from the study, because they could not be contacted. Comorbidities, preintervention BMI, glucose, HbA1c, and lipid profiles were recorded at 1, 6, and 12 months postintervention.

resultsAfter the surgery, the percent EWL was 58%. The mean serum glucose level, HbA1c level, LDL-cholesterol level, triglyceride level, insulin, and insulin resistance decreased significantly and the mean HDL-cholesterol level increased.

conclusionFor the resolution of comorbidities, LSG may be used as an effective bariatric and metabolic surgery.

Indexed as

bariatric surgerymorbid obesitySleeve gastrectomy

Identifiers

PMID26668527
PMCPMC4674040
OpenAlexW2035348883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.